Clinical Trial Update: Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain [Phase 4]

View source ↗

Summary

Phase 4 trial update on lidocaine subcutaneous infusion to control treprostinil-related site pain in pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Lidocaine (Lidocaine)
• Treprostinil (treprostinil)

Snippet

Sponsor: Jewish General Hospital | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED